Clinical trials

Clinical trial transparency at Grünenthal

The sharing of health information is fundamental for the good functioning of healthcare services, for patients’ safety, and to advance research and improve public health. Grünenthal is committed to disclosing health information, including the results of Grünenthal-sponsored clinical trials.

Grünenthal publicly committed to the Principles for Responsible Clinical Trial Data Sharing issued in January 2014 by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA). See the Grünenthal Public Disclosure Declaration to learn how Grünenthal is meeting these commitments today.

Visit the Grünenthal Clinical Trial Portal for information about Grünenthal-sponsored clinical trials. This searchable portal lists information by product, by the condition (the indication studied), by trial development phase, by status, and by trial identification number. It also provides useful links to information posted on publicly accessible registries and databases like ClinicalTrials.gov and the European Union Clinical Trials Register.